AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Building On Pandemic Progress With Barinthus Biotherapeutics' Bill Enright
Business Of Biotech
Exploring Immunotherapy Innovations in HBV and Celiac Disease
This chapter explores a biotherapeutics company's strategic focus on hepatitis B and celiac disease, backed by promising data and a unique immune tolerance platform. It also discusses investor interest in immune tolerance and its potential for broader applications in various autoimmune diseases.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode